BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. The company is headquartered in Bothell, Washington and currently employs 155 full-time employees. The firm facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during the collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the cell and gene therapy market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal closed systems are purpose-built rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The firm's ThawSTAR product line comprises a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
Mr. Roderick de Greef es el Chairman of the Board de BioLife Solutions Inc, se unió a la empresa desde 2000.
¿Qué tal es el rendimiento del precio de la acción BLFS?
El precio actual de BLFS es de $31.23, ha aumentado un 6.98% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de BioLife Solutions Inc?
BioLife Solutions Inc pertenece a la industria Life Sciences Tools & Services y el sector es Health Care
¿Cuál es la capitalización bursátil de BioLife Solutions Inc?
La capitalización bursátil actual de BioLife Solutions Inc es $1.5B
¿Es BioLife Solutions Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 11 analistas han realizado calificaciones de análisis para BioLife Solutions Inc, incluyendo 4 fuerte compra, 10 compra, 1 mantener, 0 venta, y 4 fuerte venta